Recombinant Human GJA1 Protein，His

GJA1, also known as Connexin 43 (Cx43), is a key protein in gap junctions that facilitates intercellular communication by forming channels between adjacent cells. Its role in various physiological processes, including cardiac function, cell proliferation, and differentiation, makes it a critical subject of study in cell biology and medicine. Mutations or dysregulation of GJA1 have been implicated in a variety of pathologies, including cardiac diseases, osteochondromas, and certain types of cancer. Research has increasingly focused on the recombinant expression of GJA1 to better understand its functional mechanisms and interaction with other cellular components. The production of GJA1 as a recombinant protein allows for in-depth biophysical and biochemical studies, enabling researchers to investigate its role in cell signaling and maintain overall cellular homeostasis. Additionally, insights gained from such studies can lead to novel therapeutic approaches for conditions associated with GJA1 dysfunction. As the exploration of GJA1 continues, its potential integration into gene therapy and regenerative medicine represents an exciting frontier, underlining the importance of this protein in health and disease. Understanding the structure-function relationship of GJA1 through recombinant protein studies may also pave the way for developing targeted interventions that could correct or compensate for its malfunction in various diseases. Thus, the study of GJA1 recombinant protein is not only vital for elucidating its biological significance but also for harnessing its potential in therapeutic applications.